The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab
Gespeichert in:
| Veröffentlicht in: | Australasian journal of dermatology 2024-05, Vol.65 (3), p.e63-e65 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e65 |
|---|---|
| container_issue | 3 |
| container_start_page | e63 |
| container_title | Australasian journal of dermatology |
| container_volume | 65 |
| creator | Honigman, Anthony Oo, Hnin P. Macdonell, Richard Kern, Johannes S. |
| description | |
| doi_str_mv | 10.1111/ajd.14205 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3055830062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3055830062</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3155-7ff04d0c0b123ac6256a435b865fd03e7d4df2da60418ba008b9d9bd020f7a813</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EoqUw8AeQJSaGtOfYTh22quVTFSxltuzYpqmSJjiNUPj1uA2wcctJp-eeO70IXRIYk1ATtTFjwmLgR2hIGIMI0gSO0RAAWCSogAE6a5oNAKGE81M0oIKIlFMYopfV2uJGObvrsNoabJ3LM5V1uHLYtKrAOq-K6j3MCrxbW6_q7hYv2jov2lLpw4rztlRb-7UfnKMTp4rGXvz0EXq7v1vNH6Pl68PTfLaMsv0H0dQ5YAYy0CSmKktinihGuRYJdwaonRpmXGxUAowIrQCETk2qDcTgpkoQOkLXvbf21Udrm53cVK3fhpOSAueCAiRxoG56KvNV03jrZO3zUvlOEpD75GRITh6SC-zVj7HVpTV_5G9UAZj0wGde2O5_k5w9L3rlN-eQdmY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3055830062</pqid></control><display><type>article</type><title>The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Honigman, Anthony ; Oo, Hnin P. ; Macdonell, Richard ; Kern, Johannes S.</creator><creatorcontrib>Honigman, Anthony ; Oo, Hnin P. ; Macdonell, Richard ; Kern, Johannes S.</creatorcontrib><identifier>ISSN: 0004-8380</identifier><identifier>EISSN: 1440-0960</identifier><identifier>DOI: 10.1111/ajd.14205</identifier><identifier>PMID: 38189530</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Humanized - adverse effects ; Antibodies, Monoclonal, Humanized - therapeutic use ; biologic therapy atopic dermatitis ; biologic therapy migrane ; combined biologic therapy ; Dermatitis, Atopic - drug therapy ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome</subject><ispartof>Australasian journal of dermatology, 2024-05, Vol.65 (3), p.e63-e65</ispartof><rights>2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3155-7ff04d0c0b123ac6256a435b865fd03e7d4df2da60418ba008b9d9bd020f7a813</cites><orcidid>0000-0003-2440-5128 ; 0000-0001-6604-3968 ; 0000-0002-4872-6340 ; 0000-0001-6372-8048</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajd.14205$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajd.14205$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,1414,27911,27912,45561,45562</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38189530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Honigman, Anthony</creatorcontrib><creatorcontrib>Oo, Hnin P.</creatorcontrib><creatorcontrib>Macdonell, Richard</creatorcontrib><creatorcontrib>Kern, Johannes S.</creatorcontrib><title>The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab</title><title>Australasian journal of dermatology</title><addtitle>Australas J Dermatol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>biologic therapy atopic dermatitis</subject><subject>biologic therapy migrane</subject><subject>combined biologic therapy</subject><subject>Dermatitis, Atopic - drug therapy</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Treatment Outcome</subject><issn>0004-8380</issn><issn>1440-0960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAQhi0EoqUw8AeQJSaGtOfYTh22quVTFSxltuzYpqmSJjiNUPj1uA2wcctJp-eeO70IXRIYk1ATtTFjwmLgR2hIGIMI0gSO0RAAWCSogAE6a5oNAKGE81M0oIKIlFMYopfV2uJGObvrsNoabJ3LM5V1uHLYtKrAOq-K6j3MCrxbW6_q7hYv2jov2lLpw4rztlRb-7UfnKMTp4rGXvz0EXq7v1vNH6Pl68PTfLaMsv0H0dQ5YAYy0CSmKktinihGuRYJdwaonRpmXGxUAowIrQCETk2qDcTgpkoQOkLXvbf21Udrm53cVK3fhpOSAueCAiRxoG56KvNV03jrZO3zUvlOEpD75GRITh6SC-zVj7HVpTV_5G9UAZj0wGde2O5_k5w9L3rlN-eQdmY</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Honigman, Anthony</creator><creator>Oo, Hnin P.</creator><creator>Macdonell, Richard</creator><creator>Kern, Johannes S.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0003-2440-5128</orcidid><orcidid>https://orcid.org/0000-0001-6604-3968</orcidid><orcidid>https://orcid.org/0000-0002-4872-6340</orcidid><orcidid>https://orcid.org/0000-0001-6372-8048</orcidid></search><sort><creationdate>202405</creationdate><title>The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab</title><author>Honigman, Anthony ; Oo, Hnin P. ; Macdonell, Richard ; Kern, Johannes S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3155-7ff04d0c0b123ac6256a435b865fd03e7d4df2da60418ba008b9d9bd020f7a813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>biologic therapy atopic dermatitis</topic><topic>biologic therapy migrane</topic><topic>combined biologic therapy</topic><topic>Dermatitis, Atopic - drug therapy</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Honigman, Anthony</creatorcontrib><creatorcontrib>Oo, Hnin P.</creatorcontrib><creatorcontrib>Macdonell, Richard</creatorcontrib><creatorcontrib>Kern, Johannes S.</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Australasian journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Honigman, Anthony</au><au>Oo, Hnin P.</au><au>Macdonell, Richard</au><au>Kern, Johannes S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab</atitle><jtitle>Australasian journal of dermatology</jtitle><addtitle>Australas J Dermatol</addtitle><date>2024-05</date><risdate>2024</risdate><volume>65</volume><issue>3</issue><spage>e63</spage><epage>e65</epage><pages>e63-e65</pages><issn>0004-8380</issn><eissn>1440-0960</eissn><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38189530</pmid><doi>10.1111/ajd.14205</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-2440-5128</orcidid><orcidid>https://orcid.org/0000-0001-6604-3968</orcidid><orcidid>https://orcid.org/0000-0002-4872-6340</orcidid><orcidid>https://orcid.org/0000-0001-6372-8048</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0004-8380 |
| ispartof | Australasian journal of dermatology, 2024-05, Vol.65 (3), p.e63-e65 |
| issn | 0004-8380 1440-0960 |
| language | eng |
| recordid | cdi_proquest_journals_3055830062 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adult Aged Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use biologic therapy atopic dermatitis biologic therapy migrane combined biologic therapy Dermatitis, Atopic - drug therapy Drug Therapy, Combination Female Humans Male Middle Aged Treatment Outcome |
| title | The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T14%3A48%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20safety%20and%20efficacy%20of%20dual%20biological%20therapy:%20Dupilumab%20and%20fremanezumab&rft.jtitle=Australasian%20journal%20of%20dermatology&rft.au=Honigman,%20Anthony&rft.date=2024-05&rft.volume=65&rft.issue=3&rft.spage=e63&rft.epage=e65&rft.pages=e63-e65&rft.issn=0004-8380&rft.eissn=1440-0960&rft_id=info:doi/10.1111/ajd.14205&rft_dat=%3Cproquest_cross%3E3055830062%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3055830062&rft_id=info:pmid/38189530&rfr_iscdi=true |